These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1823870)
41. Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans. Cushing DJ; Souney PF; Cooper WD; Mosher GL; Adams MP; Machatha S; Zhang B; Kowey PR Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):3-8. PubMed ID: 21933229 [TBL] [Abstract][Full Text] [Related]
42. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases. Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020 [TBL] [Abstract][Full Text] [Related]
43. Robust neuroprotective effects of 2-((2-oxopropanoyl)oxy)-4-(trifluoromethyl)benzoic acid (OPTBA), a HTB/pyruvate ester, in the postischemic rat brain. Kim SW; Lee HK; Kim ID; Lee H; Luo L; Park JY; Yoon SH; Lee JK Sci Rep; 2016 Aug; 6():31843. PubMed ID: 27545301 [TBL] [Abstract][Full Text] [Related]
44. [Pharmacokinetics of erythromycin stinoprate capsule]. Wang LQ; Hu ZY; Yu Q; Guo X; Xiong J; Huang ZZ; Cheng ZN Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):197-201. PubMed ID: 15898434 [TBL] [Abstract][Full Text] [Related]
45. Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets. García-Rafanell J; Ramis J; Gomez L; Forn J Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):155-65. PubMed ID: 3030206 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food. Kim TE; Kim JR; Jung JA; Kim MJ; Lee SY; Ko JW; Jung WT; Choi YW; Lee HJ; Kim SH; Huh W J Clin Pharm Ther; 2014 Apr; 39(2):192-5. PubMed ID: 24325365 [TBL] [Abstract][Full Text] [Related]
47. The pharmacokinetics of pioglitazone in Thai healthy subjects. Wittayalertpanya S; Chompootaweep S; Thaworn N J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065 [TBL] [Abstract][Full Text] [Related]
48. A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study. Gómez-Isla T; Blesa R; Boada M; Clarimón J; Del Ser T; Domenech G; Ferro JM; Gómez-Ansón B; Manubens JM; Martínez-Lage JM; Muñoz D; Peña-Casanova J; Torres F; Alzheimer Dis Assoc Disord; 2008; 22(1):21-9. PubMed ID: 18317243 [TBL] [Abstract][Full Text] [Related]
49. Spectroscopic and chromatographic characterization of triflusal delivery systems prepared by using supercritical impregnation technologies. Argemí A; López-Periago A; Domingo C; Saurina J J Pharm Biomed Anal; 2008 Feb; 46(3):456-62. PubMed ID: 18093783 [TBL] [Abstract][Full Text] [Related]
50. Gender related pharmacokinetics of diltiazem in healthy subjects. Sáenz-Campos D; Bayés MC; Martin S; Barbanoj MJ; Jané F Int J Clin Pharmacol Ther; 1995 Jul; 33(7):397-400. PubMed ID: 7582396 [TBL] [Abstract][Full Text] [Related]
51. Single-dose pharmacokinetics of amineptine and of its main metabolite in healthy young adults. Lachatre G; Piva C; Riche C; Dumont D; Defrance R; Mocaer E; Nicot G Fundam Clin Pharmacol; 1989; 3(1):19-26. PubMed ID: 2714729 [TBL] [Abstract][Full Text] [Related]
52. Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers. Bohner H; Janiak PS; Nitsche V; Eichinger A; Schütz H Int J Clin Pharmacol Ther; 1997 Mar; 35(3):117-22. PubMed ID: 9089001 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetics of rofecoxib in children with sickle cell hemoglobinopathy. Prescilla RP; Frattarelli DA; Haritos D; Aranda JV; Edwards DJ J Pediatr Hematol Oncol; 2004 Oct; 26(10):661-4. PubMed ID: 15454838 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects. Paczkowski D; Sadowski Z; Filipek M; Koliński P Pol J Pharmacol Pharm; 1990; 42(4):365-75. PubMed ID: 2097598 [TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics and bioavailability of percutaneous ibuprofen. Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072 [TBL] [Abstract][Full Text] [Related]